MIST Insider Trading Activity and SEC Form 4 Filings
MIST insider trading summary
Over the past 12 months, insiders at Milestone Pharmaceuticals Inc. (MIST) reported 10 sales worth $996K by 5 insiders and no open-market purchases on SEC Form 4. Net insider selling was $996K.
Latest MIST insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 26, 2026 | Lorenz Muller | Chief Commercial Officer | Sell | $22K (11,180 @ $1.93) |
| Jan 26, 2026 | Amit Hasija | CFO & EVP of Corp. Development | Sell | $24K (12,245 @ $1.93) |
| Jan 26, 2026 | Jeffrey Edward Nelson | Chief Operating Officer | Sell | $24K (12,245 @ $1.93) |
| Jan 26, 2026 | Joseph Oliveto | President and CEO | Sell | $67K (34,523 @ $1.93) |
| Jan 26, 2026 | David Bharucha | Chief Medical Officer | Sell | $24K (12,245 @ $1.93) |
| Dec 15, 2025 | Joseph Oliveto | President and CEO | Sell | $309K (133,054 @ $2.32) |
| Dec 15, 2025 | Jeffrey Edward Nelson | Chief Operating Officer | Sell | $135K (58,007 @ $2.32) |
| Dec 15, 2025 | Lorenz Muller | Chief Commercial Officer | Sell | $124K (53,566 @ $2.32) |
| Dec 15, 2025 | David Bharucha | Chief Medical Officer | Sell | $135K (58,007 @ $2.32) |
| Dec 15, 2025 | Amit Hasija | CFO & EVP of Corp. Development | Sell | $135K (58,007 @ $2.32) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.